Business
Argenx to Acquire Forte Biosciences for $2.2B
Biotech company Argenx has agreed to purchase Forte Biosciences for $2.2 billion, expanding its portfolio of treatments for autoimmune diseases.
Coverage timeline — 1 article
STAT News
Argenx plans to buy Forte Biosciences for $2.2 billion, expanding its pipeline of drugs that could treat multiple autoimmune diseases.
2026-07-27 07:26 UTC